Emerging Markets

Biosimilars are increasing in popularity with pharma companies, however, an important consideration for the interested parties is knowing which markets are saturated and which are still open, according to data and analytic company, GlobalData. more


‘Advanced simplicity’ will drive growth for inhalers in emerging markets, Peter Schmelzer, CEO of H&T Presspart tells us more. more


CPhI Russia is returning this year for its 5th edition; coinciding with the government’s Pharma 2020 plan to help stimulate demand for international pharmaceutical ingredients, manufacturing and packaging equipment. more


Suhasini Sharma, director of medical affairs at Sciformix Corporation explains how effective medical communication can pave the road to success in emerging markets. more